Colacchio Elda Chiara, Menara Sabrina, Squizzato Francesco, Piazza Michele, Menegolo Mirko, Grego Franco, Antonello Michele
Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Vascular and Endovascular Surgery Section, University of Padova, Azienda Ospedale-Università di Padova, 35128 Padova, Italy.
Life (Basel). 2024 Jun 25;14(7):798. doi: 10.3390/life14070798.
Readmissions rates and costs were analysed over follow-up for patients who underwent open or endovascular procedures for aorto-iliac occlusive disease (AIOD). Patients who underwent aorto-bifemoral bypass (ABF) or covered kissing stent (CKS) for AIOD from May 2008 to February 2018 were compared in terms of readmission rates, related costs expressed in EUR, freedom from generic readmission (FFGR), and freedom from readmission for surgical reasons (FFRS). ABF had a readmission rate of 16% and CKS of 18% ( = 0.999). The most common cause of readmission was prosthesis limb or stent occlusion. Time to readmission was longer for ABF (35 months [21-82] vs. 13.5 months [1-68.7] in the CKS group, = 0.334). CKS group had higher cumulative re-hospitalisation, ICU stay, and reintervention costs (11569 ± 2216 SEM, 2405 ± 1125, 5264 ± 1230, respectively) and a trend for more readmissions in the first 36 months, without reaching significance. This study reports on a period of time exceeding ninety days. Even if not reaching significance, the CKS group presented a higher trend in readmissions till 36 months and a higher trend in readmission costs, while time-to-readmission was longer in the ABF group.
对接受主动脉-髂动脉闭塞性疾病（AIOD）开放手术或血管内手术的患者进行随访，分析其再入院率和费用。比较了2008年5月至2018年2月期间因AIOD接受主动脉-双股动脉旁路移植术（ABF）或覆膜吻合法支架植入术（CKS）的患者的再入院率、以欧元表示的相关费用、无一般再入院情况（FFGR）以及无手术原因再入院情况（FFRS）。ABF的再入院率为16%，CKS为18%（P = 0.999）。再入院的最常见原因是假体肢体或支架闭塞。ABF的再入院时间更长（35个月[21 - 82]，而CKS组为13.5个月[1 - 68.7]，P = 0.334）。CKS组的累积再住院、ICU住院和再次干预费用更高（分别为11569 ± 2216标准误、240５ ± 1125、5264 ± 1230），且在前36个月有更多再入院的趋势，但未达到显著水平。本研究报告的时间段超过90天。即使未达到显著水平，CKS组在36个月内的再入院趋势更高，再入院费用趋势也更高，而ABF组的再入院时间更长。
